Genetic Diversity of HIV-1 and Transfusion Safety : Systematic Review and Concepts Analysis

References (50)

1. 1 Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement [DOI]
2. 2 Two Strategies for Qualitative Content Analysis: An Intramethod Approach to Triangulation [DOI]
3. 3 Blood transfusion safety in sub‐Saharan Africa: A literature review of changes and challenges in the 21st century [DOI]
4. 4 Critical appraisal of qualitative research: necessity, partialities and the issue of bias [DOI]
5. 5 HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy — Eight Sub-Saharan Africa Countries, 2013–2018 [DOI]
6. 6 Advanced Techniques in Diagnostic Microbiology [DOI]
7. 7 Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings [DOI]
8. 8 Beyond the Cut Hunter: A Historical Epidemiology of HIV Beginnings in Central Africa [DOI]
9. 9 Residual risk of HIV, HCV and HBV in Canada [DOI]
10. 10 Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso [DOI]
11. 11 Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon [DOI]
12. 12 The Precautionary Principle and the Tolerability of Blood Transfusion Risks [DOI]
13. 13 Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk [DOI]
14. 14 Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors [DOI]
15. 15 Residual risk and waste in donated blood with pooled nucleic acid testing [DOI]
16. 16 Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil [DOI]
17. 17 Transfusion Transmissible Infections: Maximizing Donor Surveillance [DOI]
18. 18 The performance of the Alere HIV combo point-of-care test on stored serum samples; useful for detection of early HIV-1 infections? [DOI]
19. 19 Efforts Toward Elimination of Infectious Agents in Blood Products [DOI]
20. 20 Transmitted drug resistance mutations and subtype diversity amongst HIV-1 sero-positive voluntary blood donors in Accra, Ghana [DOI]
21. 21 Évaluation de l’efficacité de la sélection médicale des donneurs de sang dans la prévention des agents infectieux [DOI]
22. 22 The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012–2014 [DOI]
23. 23 The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors [DOI]
24. 24 Epidemiological trends of HIV‐1 infection in blood donors from Catalonia, Spain (2005‐2014) [DOI]
25. 25 HIV-1 molecular epidemiology and drug resistance-associated mutations among treatment-naïve blood donors in China [DOI]
26. 26 The contribution of unsafe blood transfusion to human immunodeficiency virus incidence in sub‐Saharan Africa: reexamination of the 5% to 10% convention [DOI]
27. 27 IMPACT OF MULTIPLEX PCR IN REDUCING THE RISK OF RESIDUAL TRANSFUSION-TRANSMITTED HUMAN IMMUNODEFICIENCY AND HEPATITIS B AND C VIRUSES IN BURKINA FASO [DOI]
28. 28 Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries [DOI]
29. 29 NAT positivity in seronegative voluntary blood donors from western India [DOI]
30. 30 Homogenous HIV-1 subtype B from the Brazilian Amazon with infrequent diverse BF1 recombinants, subtypes F1 and C among blood donors [DOI]
31. 31 A study of centralized individual donor nucleic acid testing for transfusion transmitted infections to improve blood safety in Karnataka, India [DOI]
32. 32 Residual risk of HIV transmission through blood transfusion in five blood banks in Cameroon [DOI]
33. 33 The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014–2017 [DOI]
34. 34 Prevalence of Transfusion Transmissible Infections in a Nigerian Tertiary Hospital [DOI]
35. 35 High rate of seromarkers for HIV, HBV and syphilis among blood donors using confidential unit exclusion, before and after HIV‐NAT implementation at a major public blood bank in the Brazilian Amazon [DOI]
36. 36 High Prevalence of Hepatitis B Virus Infection Compared to Human Immunodeficiency Virus among Blood Donors in Bangui [DOI]
37. 37 Genetic Diversity and Transmitted Drug Resistance of HIV-1 Subtypes in Blood Donors Candidates in Northern Mozambique [DOI]
38. 38 Efficacy of Nucleic Acid Amplification Test (NAT) over Enzyme Linked Immuno Sorbent Assay (ELISA) in Detecting Transfusion Transmissible Infections (TTI) among Blood Donors at a Tertiary Care Centre [DOI]
39. 39 Residual Risk of HIV in African Transfusional Setting: Systematic Review and Meta-Analysis [DOI]
40. 40 Genetic Diversity of Human Immunodeficiency Virus Type 1 in Asymptomatic Blood Donors in Islamabad, Pakistan [DOI]
41. 41 Genetic Analysis of HIV-1 in Japan: a Comprehensive Analysis of Donated Blood [DOI]
42. 42 Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF77_cpx) Identified among Blood Donors in Malaysia [DOI]
43. 43 Near Full-Length Genome Sequence of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) Detected Among Blood Donors in North China [DOI]
44. 44 Molecular Techniques for Blood and Blood Product Screening [DOI]
45. 45 Nucleic Acid Amplification Testing Detects HIV Transmission Risk in Serologically-Tested Blood Donor Units [DOI]
46. 46 HIV risk associated with nucleic acid testing tested seronegative blood donation where the donor was not preassessed for the risk [DOI]
47. 47 JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH [DOI]
48. 48 PNS154 THE PRISMA 2020 STATEMENT: DEVELOPMENT OF AND KEY CHANGES IN AN UPDATED GUIDELINE FOR REPORTING SYSTEMATIC REVIEWS AND META-ANALYSES [DOI]
49. 49 Emerging Infections and Transfusion Safety [DOI]
50. 50 Detection of Early HIV-1 Infection among Febrile Persons and Blood Donors in Oyo State, Nigeria [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Co-inheritance of Glucose-6-phosphate dehydrogenase Deficiency and Sickle Cell Traits in Sokoto Metropolis — shares topic coverage
• Bloodless Medicine and Surgery: A Review of Practice and Consideration of Jehova Witnesses — shares topic coverage
• Compliance with the Informed Consent to Blood Transfusion: Constraints and Physic for the Developing Africa — shares topic coverage
• Direct-Push Blood Transfusion Practice in the Neonatal Unit of a Tertiary Hospital in South-South, Nigeria — shares topic coverage
• Evaluation of Knowledge, Attitude and Practice of Voluntary Blood Donation among Healthcare Support Staff of a Tertiary Health Facility in Uyo, Nigeria — shares topic coverage